Histological evaluation of AMPK signalling in primary breast cancer
about
AMPK: opposing the metabolic changes in both tumour cells and inflammatory cells?Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human StudiesAminoimidazole carboxamide ribonucleotide (AICAR) inhibits the growth of retinoblastoma in vivo by decreasing angiogenesis and inducing apoptosisInhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cellsMetformin effects on biochemical recurrence and metabolic signaling in the prostate.Metformin-treated cancer cells modulate macrophage polarization through AMPK-NF-κB signaling.The RNA helicase/transcriptional co-regulator, p68 (DDX5), stimulates expression of oncogenic protein kinase, Polo-like kinase-1 (PLK1), and is associated with elevated PLK1 levels in human breast cancersAMPK as a metabolic tumor suppressor: control of metabolism and cell growth.Prognostic significance of AMPK activation in advanced stage colorectal cancer treated with chemotherapy plus bevacizumab.The effect of 5-aminoimidazole-4-carboxamide-ribonucleoside was mediated by p38 mitogen activated protein kinase signaling pathway in FRO thyroid cancer cells.Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer.Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery.A novel dysregulated pathway-identification analysis based on global influence of within-pathway effects and crosstalk between pathways.AMPK-activated protein kinase activation by Impatiens balsamina L. is related to apoptosis in HSC-2 human oral cancer cellsInvolvement of metformin and AMPK in the radioresponse and prognosis of luminal versus basal-like breast cancer treated with radiotherapyAssociation between phosphorylated AMP-activated protein kinase and acetyl-CoA carboxylase expression and outcome in patients with squamous cell carcinoma of the head and neck.The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels.Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study.MAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4Metformin and the ATM DNA damage response (DDR): accelerating the onset of stress-induced senescence to boost protection against cancerTargeting AMPK for cancer prevention and treatment.AMP-activated kinase (AMPK) regulates activity of HER2 and EGFR in breast cancer.Molecular Pathways: Is AMPK a Friend or a Foe in Cancer?Immunohistochemical detection of Polo-like kinase-1 (PLK1) in primary breast cancer is associated with TP53 mutation and poor clinical outcomAMPK Inhibits the Stimulatory Effects of TGF-β on Smad2/3 Activity, Cell Migration, and Epithelial-to-Mesenchymal Transition.ATM and LKB1 dependent activation of AMPK sensitizes cancer cells to etoposide-induced apoptosisAMP-Activated Protein Kinase Signalling in Cancer and Cardiac Hypertrophy.AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo.LKB1/AMPK inhibits TGF-β1 production and the TGF-β signaling pathway in breast cancer cells.AMP-Activated Protein Kinase α 2 Isoform Suppression in Primary Breast Cancer Alters AMPK Growth Control and Apoptotic Signaling.Potential applications for biguanides in oncologyGroup X secreted phospholipase A(2) induces lipid droplet formation and prolongs breast cancer cell survival.mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPK.AMPKα Is Suppressed in Bladder Cancer through Macrophage-Mediated Mechanisms.Gene co-expression network analysis reveals common system-level properties of prognostic genes across cancer types.AMP-activated protein kinase and energy balance in breast cancer.Perspectives of the AMP-activated kinase (AMPK) signalling pathway in thyroid cancer.Metabolic alterations in cancer cells and therapeutic implications.Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies.Role of AMP-activated protein kinase in cancer therapy.
P2860
Q26866512-C00DA63C-B58E-48F6-9C55-4EFBAB26EFF2Q28081491-2BB36BC4-3A81-400C-9D8C-BF91BFF63E10Q28484822-6D7BCDCB-EA44-4A27-BE26-5443C17B396BQ29303134-54546C01-C0E3-456A-9943-CB643A93E395Q30665188-F589FA55-EA0B-4F63-9960-DA6210A0F620Q33591312-84069535-51BF-47CC-9EC8-A264DEEB6C1FQ33728889-1ECABBBD-DE9E-45F9-A77E-342BC73130E7Q33789079-8D07195F-C0F3-4ECC-8E28-717AD1384D70Q33877467-E4FCFCC6-4D10-4EFB-ADA6-41206BCAB2A1Q33912895-3E036C8F-958C-4A8F-B0F1-E8288D8FCB96Q34250109-B5D89349-4DF8-4F59-BDE4-581E7F44AF67Q34283721-102D44E2-50E0-4FDB-A67F-E723BE97B565Q34775286-BA7E994E-4702-4D79-88D4-8305394D0B18Q35086813-8C3973BF-1F36-4178-85D3-59CD911C6D80Q35149589-AB752588-F08E-408A-A988-3069E711EE98Q35158141-1846F195-204D-48F3-ACCE-3ED2F696CD44Q35215557-4B29A56D-5C7D-4B7D-8BCB-E5C59B54B26EQ35238162-8A46560C-1751-4AA7-90A2-9C7B0E42CB4DQ35637193-8420BD83-D3FC-4F55-A8D5-EA39D1B3DBCCQ35645149-C8E7E81F-334F-482D-AD68-E6167E23BB85Q35781311-73D0E82B-75CB-49F6-8BA7-FBCDC3263587Q36020830-F950D241-8A91-4F18-8BA3-D6F791E46DF0Q36023587-4347D767-17D3-4EBE-9C8D-9C27B233F2BFQ36245509-19936092-73B8-4696-B96E-D1B589EFCCD9Q36316820-3C99671D-241B-49CE-BCB7-FE0B33C0B086Q36465010-1B0F6F13-04B0-437D-AA1C-2142DE747E1FQ36479047-FC34D758-FC11-4401-AD4F-ED09E7C448F5Q36532941-5530801D-6101-4B2B-ADE5-9914B0DA0DF3Q36924111-84F29758-4AFF-4095-8524-A31F38749966Q37094565-60471668-B3C0-4E75-906F-D9DCB55AA13FQ37123877-85782340-F703-4FDC-A4AB-18DE81EDE4CEQ37367844-15F76D4D-3045-465C-8629-D2D3FD1E04F9Q37376505-FC1FF648-D15A-4215-B3AA-7520D487890FQ37482647-0B264609-C85A-43EB-82EB-54D0A1842E11Q37632815-D24B0FC2-03CA-417C-B898-B608DC219CC7Q37685196-42EA1C67-B734-4B2F-9C82-5634B4509779Q37702988-666905D0-8FE0-4031-A0E9-8ED8233F02AEQ37908233-E2FB635A-294A-4B10-BFB1-E07F4A65FD42Q38017727-A10E7DF7-0622-49BB-9FF3-577198106EF8Q38200018-23B76782-1385-41F2-BDF3-AD3662D0D9DB
P2860
Histological evaluation of AMPK signalling in primary breast cancer
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Histological evaluation of AMPK signalling in primary breast cancer
@ast
Histological evaluation of AMPK signalling in primary breast cancer
@en
type
label
Histological evaluation of AMPK signalling in primary breast cancer
@ast
Histological evaluation of AMPK signalling in primary breast cancer
@en
prefLabel
Histological evaluation of AMPK signalling in primary breast cancer
@ast
Histological evaluation of AMPK signalling in primary breast cancer
@en
P2093
P2860
P50
P356
P1433
P1476
Histological evaluation of AMPK signalling in primary breast cancer
@en
P2093
Alastair M Thompson
David Kellock
George Thomson
Katherine E Robertson
Lee B Jordan
Sirwan M Hadad
Stewart Fleming
Susan E Bray
P2860
P2888
P356
10.1186/1471-2407-9-307
P407
P577
2009-09-01T00:00:00Z
P5875
P6179
1032498636